Lung Cancer Vaccine Market Lung Cancer Vaccine Clinical Pipeline Report 2022

For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990

Report Table of Contents

What are Cancer Vaccines?

Mechanism of Cancer Vaccines
2.1 Idiotype Cancer Vaccine Mechanism
2.2 Cellular Cancer Vaccines Mechanism
2.3 Ganglioside Antigens based Cancer Vaccines Mechanism
2.4 Peptide Cancer Vaccine Mechanism
2.5 Tumor Host Interaction Cancer Vaccine Mechanism

Overview of Lung Cancer Proliferation
3.1 Lung Cancer Invasion
3.1.1 Transformation of Normal Cell into Cancerous Cell
3.1.2 Tumor Heterogeneity and Cancer Stem Cells
3.1.3 Dissemination of Tumor Cell and Cell Motility
3.2 Lung Cancer Metastasis
3.2.1 Angiogenesis and Lymphangiogenesis
3.2.2 Intravasation, Circulation and Extravasation

Lung Cancer Vaccine Mechanism
4.1 Mechanism of Lung Cancer Vaccination
4.2 Rationale for Using Lung Cancer Vaccines
4.2.1 Regulatory T- Lymphocytes (Tregs)
4.2.2 Macrophages

Clinical Trials of Lung Cancer Vaccines

Global Lung Cancer Incidence Rate
6.1 U.S
6.2 Europe
6.3 Asia
6.4 Rest of the World

Global Lung Cancer Vaccine Market Overview
7.1 Current Market Scenario
7.2 Global Lung Cancer Vaccine Pipeline Overview
7.3 Global Lung Cancer Vaccine Market Future Prospects

Need for Personalized Breast Cancer Vaccines

Lung Cancer Vaccine Clinical Pipeline by Company and Phase
9.1 Preclinical
9.2 Phase-I
9.3 Phase-II

Non Small Cell Lung Cancer Vaccine Clinical Pipeline by Company and Phase
10.1 Research
10.2 Preclinical
10.3 Phase-I
10.4 Phase-I/II
10.5 Phase-II
10.6 Phase-II/III
10.7 Phase-III

Small cell lung Cancer Vaccine Clinical Pipeline by Company and Phase
11.1 Phase-II

Marketed Lung Cancer Vaccine Clinical and Patent Insight
12.1 Epidermal Growth Factor Cancer Vaccine
12.2 Mycidac-Candtrade;
12.3 Racotumomab (Vaxira)

No Development Reported and Discontinued Lung Cancer Vaccine Clinical Pipeline by Company, Indication and Phase
13.1 No Development Reported
13.2 Discontinued
13.3 Suspended

Competitive Landscape
14.1 Argos Therapeutics
14.2 Boehringer Ingelheim
14.3 Cadila Pharmaceuticals
14.4 CureVac
14.5 Eli Lily
14.6 Galaxo
14.7 ImClone Systems
14.8 Inovio Pharmaceuticals
14.9 Merck
14.10 NewLink Genetics
14.11 Northwest Biotherapeutics
14.12 Ono Pharmaceutical
14.13 Oncothyreon Incorporation
14.14 OSE Immunotherapeutics

Download Report:https://www.kuickresearch.com/report-global-lung-cancer-vaccine-market-and-pipeline-outlook-2022.php

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
Avanta Business Center 4th Floor,
Statesman House Barakhamba Road,
Connaught Place New Delhi – 110 001, India
+91-11-47067990

This release was published on openPR.